Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.01 – $0.08
34% from low
Exchange
OTC Link
OS
Borrow rate
0.32%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $96.4K | $302.4K | $750.0K | $224.9K | $138.2K | $61.9K | $113.2K | $67.8K |
| Cost of revenue | $13.9K | $18.4K | $202.0K | $37.0K | $3.0K | $7.8K | $27.5K | $380.0K |
| Gross profit | $82.5K | $283.9K | $548.0K | $188.0K | $135.2K | $54.1K | $85.7K | −$312.2K |
| Gross margin | 85.6% | 93.9% | 73.1% | 83.6% | 97.8% | 87.4% | 75.7% | -460.3% |
| R&D | $63.9K | $80.0K | $130.4K | $83.1K | $65.3K | $8.8K | $12.5K | $0 |
| Operating income | −$412.7K | −$834.3K | −$934.8K | −$1.5M | −$738.7K | −$695.1K | −$479.0K | −$597.7K |
| EBITDA | −$409.7K | −$831.7K | −$1.2M | −$1.5M | −$786.7K | −$778.8K | −$404.1K | −$597.7K |
| Net income | −$508.4K | −$835.9K | −$1.2M | −$2.4M | −$794.1K | −$813.1K | −$456.2K | −$630.7K |
| Net margin | -527.3% | -276.5% | -158.0% | -1064.1% | -574.8% | -1312.9% | -402.9% | -929.9% |
| EPS (diluted) | -0.03 | -0.05 | -0.04 | -0.08 | -0.03 | -0.03 | -0.01 | -0.02 |
Annual figures · source: Financial Modeling Prep
OVATION SCIENCE INC
No one on the platform currently holds OVATF.
No tracked institution reports a position in OVATF as of their last filing.
No one on the platform has traded OVATF yet.
| $2M |
| — |
| EDXCEndexx Corporation | $0.00 | +0.00% | $57185 | — |
| ELLXFElixinol Wellness Limited | $0.01 | +0.00% | $2M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 11.4× sales vs its 11.6× historical median P/S.
Fair value ≈ $0.04 · price $0.04 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.